Loomis, Sayles & Company’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SRDX
TI
RA
TA
Loomis, Sayles & Company's SRDX Position: Q4 2017 in Review
Loomis, Sayles & Company sold out of Surmodics (SRDX) in Q4 2017, closing a stake of 124 shares — an estimated $4K sold.
Loomis, Sayles & Company first reported a position in SRDX in Q2 2013 and held it in 17 quarters. The position peaked at $8.5M in Q3 2016. 115 funds tracked by Wall St. Rank hold SRDX as of Q4 2017.
- Loomis, Sayles & Company reported no remaining Surmodics position as of Q4 2017 after selling out during the quarter.
- Loomis, Sayles & Company sold 124 Surmodics shares in Q4 2017, an estimated $4K.
- Loomis, Sayles & Company first reported a position in Surmodics in Q2 2013 and held it in 17 quarters.
- Loomis, Sayles & Company's Surmodics position peaked at $8.5M in Q3 2016.
- 115 funds tracked by Wall St. Rank held Surmodics as of Q4 2017.
Based on Loomis, Sayles & Company's 13F filing for Q4 2017, filed 14 Feb 2018.